
Revolutionary Breakthrough: Unleashing the Power of IgE Antibodies in the Fight Against Aggressive Cancer
Researchers at King’s College London, led by Dr. Heather Bax, are developing IgE antibodies as a new form of cancer immunotherapy. Traditional IgG antibody treatments against the HER2 marker in breast and ovarian cancer are often ineffective. IgE antibodies are reprogramming the